Close
4

Athena Athena

X

Find Crisaborole manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Looking for 906673-24-3 / Crisaborole API manufacturers, exporters & distributors?

Crisaborole manufacturers, exporters & distributors 1

43

PharmaCompass offers a list of Crisaborole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Crisaborole manufacturer or Crisaborole supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Crisaborole manufacturer or Crisaborole supplier.

PharmaCompass also assists you with knowing the Crisaborole API Price utilized in the formulation of products. Crisaborole API Price is not always fixed or binding as the Crisaborole Price is obtained through a variety of data sources. The Crisaborole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Crisaborole

Synonyms

906673-24-3, An-2728, An2728, 4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile, Eucrisa, An 2728

Cas Number

906673-24-3

Unique Ingredient Identifier (UNII)

Q2R47HGR7P

About Crisaborole

Crisaborole is a novel oxaborole approved by FDA on December 14, 2016 as Eucrisa, a topical treatment of for mild to moderate atopic dermatitis. This non-steroidal agent is efficacious in improving disease severity, reducing the risk of infection and reducing the signs and symptoms in patients 2 years old and older. It reduces the local inflammation in the skin and prevents further exacerbation of the disease with a good safety profile. Its structure contains a boron atom, which facilitates skin penetration and binding to the bimetal center of the phosphodiesterase 4 enzyme. It is currently under development as topical treatment of psoriasis.

Crisaborole Manufacturers

A Crisaborole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crisaborole, including repackagers and relabelers. The FDA regulates Crisaborole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crisaborole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Crisaborole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Crisaborole Suppliers

A Crisaborole supplier is an individual or a company that provides Crisaborole active pharmaceutical ingredient (API) or Crisaborole finished formulations upon request. The Crisaborole suppliers may include Crisaborole API manufacturers, exporters, distributors and traders.

click here to find a list of Crisaborole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Crisaborole USDMF

A Crisaborole DMF (Drug Master File) is a document detailing the whole manufacturing process of Crisaborole active pharmaceutical ingredient (API) in detail. Different forms of Crisaborole DMFs exist exist since differing nations have different regulations, such as Crisaborole USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Crisaborole DMF submitted to regulatory agencies in the US is known as a USDMF. Crisaborole USDMF includes data on Crisaborole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Crisaborole USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Crisaborole suppliers with USDMF on PharmaCompass.

Crisaborole WC

A Crisaborole written confirmation (Crisaborole WC) is an official document issued by a regulatory agency to a Crisaborole manufacturer, verifying that the manufacturing facility of a Crisaborole active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Crisaborole APIs or Crisaborole finished pharmaceutical products to another nation, regulatory agencies frequently require a Crisaborole WC (written confirmation) as part of the regulatory process.

click here to find a list of Crisaborole suppliers with Written Confirmation (WC) on PharmaCompass.

Crisaborole NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Crisaborole as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Crisaborole API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Crisaborole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Crisaborole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Crisaborole NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Crisaborole suppliers with NDC on PharmaCompass.

Crisaborole GMP

Crisaborole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Crisaborole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Crisaborole GMP manufacturer or Crisaborole GMP API supplier for your needs.

Crisaborole CoA

A Crisaborole CoA (Certificate of Analysis) is a formal document that attests to Crisaborole's compliance with Crisaborole specifications and serves as a tool for batch-level quality control.

Crisaborole CoA mostly includes findings from lab analyses of a specific batch. For each Crisaborole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Crisaborole may be tested according to a variety of international standards, such as European Pharmacopoeia (Crisaborole EP), Crisaborole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Crisaborole USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY